Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This prospective, multicenter, single arm clinical trial was designed to evaluate the
efficacy and safety of Vemurafenib in combination with Irinotecan and Cetuximab in the
treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer.